|
Post by orlon on Jul 2, 2015 9:49:30 GMT -5
Anyone know who/what/why the PPS is being hammered again today? This seems to be an ongoing thing. Several folks at the YMB are pointing their fingers at Sanofi and I have admit I'm intrigued by some of their arguments. I personally never thought much of a 'slow roll out.' If you have a blockbuster drug that would help millions and make millions why not get out in front of it? An ad of some vagrant 'breathing easy' could as well have been an ad for how to get Uncle Bill off the crack (photo-shop the dreamboat for a crack pipe.) It's almost 8:00 am...I'm going to get hammered!
|
|
|
Post by chicagpete on Jul 2, 2015 10:02:06 GMT -5
Just boarded a flight for holiday weekend with my daughter. Bought more shares this morning with monthly income from schwab lending program. IMO - after continuing to try and put all pieces of this puzzle together - the future looks very bright!!!! Hope everyone has great 4th!
|
|
|
Post by mbseeking on Jul 2, 2015 10:03:07 GMT -5
In the short run , MNKD's price is probably more influenced by how full the short seller's coffer's are. We are in the pause between ADA and DTC on an assumed uplift in scripts so they are making a run for it . To their advantage they are well financed (my guess) and , despite what should be right, can create a large volume of even naked shorts. You'll note that the volume today is not yet large so they haven't even had to spend much to drive the price down.
Has the big picture changed ? No.
What they are betting on is that that script report this Friday.. and the next few dont start to tick up. Truth is no one really knows.. that is real world uncertainty. If they are right, and they dont , then they win. If they are wrong , and the scripts really start increasing .. they are smoked. I think it is that simple.
|
|
|
Post by liane on Jul 2, 2015 10:07:20 GMT -5
We're being hammered because of low volume going into holiday weekend. Same old story; nothing to see here.
|
|
|
Post by ripano on Jul 2, 2015 10:15:06 GMT -5
Institutional accounts are not finished buying yet. They will be forced to cover soon.
|
|
|
Post by patryn on Jul 2, 2015 11:49:38 GMT -5
On such low volume, one or two motivated traders can change the price pretty easily. I picked up a few more shares at the bargain bin today.
|
|
|
Post by mnholdem on Jul 2, 2015 11:58:35 GMT -5
Pretty much all my bio-stocks are showing red today. Not a big deal to me, this day-to-day activity.
|
|
|
Post by babaoriley on Jul 2, 2015 12:16:39 GMT -5
The share price is all about the financial side of MNKD stock, i.e., shorters, day-traders, dastardly and nefarious articles, etc.
While the above is distasteful and unpleasant, I prefer to focus on the business side of MNKD, where we are "on the brink" of many things, and where we continue to hear far more good than bad when it comes to early results from Afrezza users.
There is a clear and wide dichotomy between the financial side and the business side. It's not going to happen quickly, but eventually, the business side will more directly influence the financial side and the share price will start to rise, if we've been correct all these years about the potential for Afrezza and TS. Spirometry, insurance stuff, etc., they will be overcome. Eventually, foreign sales, that's going to be a big boost for us.
For now, though, this is what we've got.
|
|
|
Post by Chris-C on Jul 3, 2015 10:34:20 GMT -5
The share price is all about the financial side of MNKD stock, i.e., shorters, day-traders, dastardly and nefarious articles, etc. While the above is distasteful and unpleasant, I prefer to focus on the business side of MNKD, where we are "on the brink" of many things, and where we continue to hear far more good than bad when it comes to early results from Afrezza users. There is a clear and wide dichotomy between the financial side and the business side. It's not going to happen quickly, but eventually, the business side will more directly influence the financial side and the share price will start to rise, if we've been correct all these years about the potential for Afrezza and TS. Spirometry, insurance stuff, etc., they will be overcome. Eventually, foreign sales, that's going to be a big boost for us. For now, though, this is what we've got. Baba Nice post! The wide gap between the financial side and the business side is also a function of the vulnerability and popularity of a stock. Market sentiment for loved fairytale stocks can drive a stock's share price to levels unjustified by its financials. Investing is both an art and a science, since emotions as well as logic can prevail to influence share price. It's obvious that Mannkind is not a darling of Wall Street, and probably for several reasons. So any gains are going to have to be earned the hard way. In my investing experience, slow and steady is a fine pace for a long marathon, and that is the metaphorical event we are participating in now. Patience will be rewarded. Enjoy the Fourth! Chris C
|
|
|
Post by mnholdem on Jul 3, 2015 20:32:27 GMT -5
May the 4th be with you, board members.
|
|